<p>Tata Medical & Diagnostics is said to have started initial discussions with Moderna Inc for a partnership to launch its Covid-19 vaccine in India, the <em>Economic Times</em> reported on Monday.</p>.<p>Tata could team up with the Council of Scientific & Industrial Research (CSIR) to carry out clinical trials of Moderna's vaccine candidate in India, the <a href="https://bit.ly/2Yd8E2B" target="_blank">report</a> added, citing officials familiar with the matter.</p>.<p><a href="https://www.deccanherald.com/national/coronavirus-vaccine-live-news-updates-astrazeneca-oxford-bharat-biotech-covaxin-covishield-healthworkers-free-vaccine-vaccination-drive-india-serum-institute-narendra-modi-943022.html#1" target="_blank"><strong>Follow coronavirus vaccine live updates only on DH</strong></a></p>.<p>The Indian government this month gave emergency-use approval to a Covid-19 vaccine developed by Bharat Biotech International Ltd and state-run Indian Council of Medical Research, and another licensed from Oxford University and AstraZeneca PLC that is being manufactured by the Serum Institute of India.</p>.<p>Moderna did not respond to <em>Reuters</em>' request for a comment outside business hours, while Tata Medical & Diagnostics did not immediately respond.</p>
<p>Tata Medical & Diagnostics is said to have started initial discussions with Moderna Inc for a partnership to launch its Covid-19 vaccine in India, the <em>Economic Times</em> reported on Monday.</p>.<p>Tata could team up with the Council of Scientific & Industrial Research (CSIR) to carry out clinical trials of Moderna's vaccine candidate in India, the <a href="https://bit.ly/2Yd8E2B" target="_blank">report</a> added, citing officials familiar with the matter.</p>.<p><a href="https://www.deccanherald.com/national/coronavirus-vaccine-live-news-updates-astrazeneca-oxford-bharat-biotech-covaxin-covishield-healthworkers-free-vaccine-vaccination-drive-india-serum-institute-narendra-modi-943022.html#1" target="_blank"><strong>Follow coronavirus vaccine live updates only on DH</strong></a></p>.<p>The Indian government this month gave emergency-use approval to a Covid-19 vaccine developed by Bharat Biotech International Ltd and state-run Indian Council of Medical Research, and another licensed from Oxford University and AstraZeneca PLC that is being manufactured by the Serum Institute of India.</p>.<p>Moderna did not respond to <em>Reuters</em>' request for a comment outside business hours, while Tata Medical & Diagnostics did not immediately respond.</p>